Jackson, D. O., Byrd, K., Vreeland, T. J., Hale, D. F., Herbert, G. S., Greene, J. M., . . . Peoples, G. E. (2016). Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients. Oncotarget.
Chicago-stil citatJackson, Doreen O., et al. "Interim Analysis of a Phase I/IIa Trial Assessing E39+GM-CSF, a Folate Binding Protein Vaccine, to Prevent Recurrence in Ovarian and Endometrial Cancer Patients." Oncotarget 2016.
MLA-referensJackson, Doreen O., et al. "Interim Analysis of a Phase I/IIa Trial Assessing E39+GM-CSF, a Folate Binding Protein Vaccine, to Prevent Recurrence in Ovarian and Endometrial Cancer Patients." Oncotarget 2016.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.